Results 121 to 130 of about 92,853 (340)
Adapting clinical guidelines to take account of multimorbidity [PDF]
Most people with a chronic condition have multimorbidity, but clinical guidelines almost entirely focus on single conditions. It will never be possible to have good evidence for every possible combination of conditions, but guidelines could be made more ...
Alderson, P.+4 more
core +1 more source
The analysis workflow, findings and potential clinical consequences of iron deficiency in heart failure (HF). From 881 patients with worsening HF, whole blood transcriptome was analysed using the Affymetrix Human Transcriptome Array (HTA) 2.0. Subjects were stratified according to their transferrin saturation (TSAT) levels as iron‐deficient (TSAT <20%)
Niels Grote Beverborg+17 more
wiley +1 more source
Clinical evidence in transcatheter edge‐to‐edge valve repair. EF, ejection fraction; eGFR, estimated glomerular filtration rate; EROA, effective regurgitant orifice area; GDMT, guideline‐directed medical therapy; HF, heart failure; HHF, hospitalization for heart failure; LVEDV, left ventricular end‐diastolic volume; MR, mitral regurgitation; MVARC ...
Gianluigi Savarese+13 more
wiley +1 more source
A Review Article About Digoxin-Herb and Dietary Supplement Interactions
Digoxin has a narrow therapeutic index and is the potential drug for interaction with other drugs, herbs and supplements, therefore, regarded to these properties we decided to review the evidence about interaction between herbal-dietary supplements and ...
Forouzan ahmadpour *, Fatemeh Ahmadpour
doaj
AIM To review digoxin use in systolic congestive heart failure, atrial fibrillation, and after myocardial infarction. METHODS A comprehensive PubMed search was performed using the key words "digoxin and congestive heart failure", "digoxin and atrial ...
Sebastiano Virgadamo+4 more
semanticscholar +1 more source
Abstract This clinical consensus statement revisits the role of left ventricular ejection fraction (LVEF) as a measurement of cardiac function, a prognostic marker and a major criterion to classify patients with heart failure, and gives new advice for clinical practice.
Giuseppe M.C. Rosano+20 more
wiley +1 more source
Some Effects of Digoxin upon the Heart and Circulation in Man [PDF]
M. IRENÉ FERRER+5 more
openalex +1 more source
Selective cell death of latently HIV-infected CD4+ T cells mediated by autosis inducing nanopeptides. [PDF]
Despite significant advances in the treatment of human immunodeficiency virus type-1 (HIV) infection, antiretroviral therapy only suppresses viral replication but is unable to eliminate infection. Thus, discontinuation of antiretrovirals results in viral
Campbell, Grant R+6 more
core
Allelic variations of the multidrug resistance gene determine susceptibility and disease behavior in ulcerative colitis [PDF]
BACKGROUND AND AIMS: The MDR1 gene encodes P-glycoprotein 170, an efflux transporter that is highly expressed in intestinal epithelial cells. The MDR1 exonic single nucleotide polymorphisms (SNPs) C3435T and G2677T have been shown to correlate with ...
Arnott, Ian D+7 more
core +1 more source
Finerenone and glycaemic status in patients with heart failure with mildly reduced/preserved ejection fraction. CI, confidence interval; CV, cardiovascular; HF, heart failure; HR, hazard ratio; RR, rate ratio. Abstract Aims The efficacy and safety of the non‐steroidal mineralocorticoid receptor antagonist, finerenone, have not been examined in patients
Jawad H. Butt+18 more
wiley +1 more source